Pharmesis International Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmesis International Ltd with three other
pharmaceutical manufacturers in Asia:
Godavari Drugs Ltd
sales of 755.99 million Indian Rupees [US$10.59 million]
UBI Pharma Inc
(332.84 million Taiwanese Dollars [US$10.79 million]
of which 100%
was Single Segment), and
Parabolic Drugs Limited
based in India
(749.01 million Indian Rupees [US$10.49 million]
During the year ended December of 2017, sales at
Pharmesis International Ltd were 14.22 million Singapore Dollars (US$10.47 million).
decrease of 0.5%
versus 2016, when the company's sales were 14.29 million Singapore Dollars.